The unique plasma assets serve as the foundation of the Chronos-PD program, driving advanced research at Grifols subsidiary Alkahest, which is leading the initiative given its specialization in the ...
Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...
News Medical on MSN14h
Grifols receives grant for early Parkinson's disease biomarker discoveryGrifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
"Grifols developed its new fibrinogen to be more convenient, faster to prepare and storable at room temperature, an advantage over alternatives such as cryoprecipitate or fresh frozen plasma when ...
On Wednesday, Grifols SA (NASDAQ:GRFS) said it ended discussions with Brookfield Capital Partners (UK) Limited about a potential acquisition. This decision follows the company’s November 19 ...
Will fund a pilot study to analyze longitudinal plasma samples covering a period of up to 10 years.
The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Character Abbotsford's next big event is the Character in Action Awards on May 8, 2025. The venue is still be determined, but ...
Five years after the COVID-19 pandemic began, millions who are considered immunocompromised still avoid crowds and even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback